Summit Therapeutics Plc Ord 1P is listed on the London Stock Exchange trading with ticker code SUMM.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £4,253m, with approximately 160m shares in issue. Over the last year, Summit Therapeutics Plc share price has been traded in a range of 185.5, hitting a high of 202.50, and a low of 17.00.
Summit Therapeutics Plc is in the Medicine and Biotech Research sector.
|Accsys Technologies Plc (AXS.L)|
|Churchill China Plc (CHH.L)|
|Eckoh Plc (ECK.L)|
|Hargreaves Services Plc (HSP.L)|
|Brady Plc (BRY.L)|
|Shares in Issue||160m|
|52 Week High||202.50|
|52 Week Low||17.00|